Literature DB >> 25830839

Rebuilding the injured lung.

Peter B Bitterman1.   

Abstract

The 57th annual Thomas L. Petty Aspen Lung Conference, entitled "Rebuilding the Injured Lung," was held from June 4 to 7, 2014 at the Gant Conference Center in Aspen, Colorado. Investigators from a wide range of disciplines and perspectives convened to discuss the biology of lung injury, how the lung repairs itself, how and why repair fails, and how the repair process can be enhanced. Among the challenges identified in the course of the conference was how to develop more predictive experimental models that capture the multidimensional complexity of lung injury and repair in a tractable manner. From such approaches that successfully fuse the biological and physical sciences, the group envisioned that new therapies for acute and chronic lung injury would emerge. The discussion of experimental therapeutics ranged from pharmaceuticals and cells that interdict fibrosis and enhance repair to a de novo lung derived from stem cells repopulating a decellularized matrix.

Entities:  

Keywords:  biomechanics; fibrosis; injury; regeneration; repair

Mesh:

Year:  2015        PMID: 25830839      PMCID: PMC5467108          DOI: 10.1513/AnnalsATS.201411-529MG

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  4 in total

1.  Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis.

Authors:  Hong Xia; Vidya Bodempudi; Alexey Benyumov; Polla Hergert; Damien Tank; Jeremy Herrera; Jeff Braziunas; Ola Larsson; Matthew Parker; Daniel Rossi; Karen Smith; Mark Peterson; Andrew Limper; Jose Jessurun; John Connett; David Ingbar; Sem Phan; Peter B Bitterman; Craig A Henke
Journal:  Am J Pathol       Date:  2014-03-13       Impact factor: 4.307

Review 2.  Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control.

Authors:  Hans Clevers; Kyle M Loh; Roel Nusse
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

Review 3.  The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.

Authors:  Randy Johnson; Georg Halder
Journal:  Nat Rev Drug Discov       Date:  2013-12-13       Impact factor: 84.694

4.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.